(VAP-1,72.24361734102048)
(ST-2,72.24361734102048)
(l-3,67.42737618495245)
(exosomes,57.79489387281639)
(SPC24,57.79489387281639)
(BRCC3,57.79489387281639)
(β-SDG,52.97865271674835)
(microRNA-22,48.16241156068032)
(miR‑511,43.34617040461229)
(vena,43.34617040461229)
(cava,43.34617040461229)
(neuropathy,43.34617040461229)
(leaf,38.529929248544256)
(rs5743810,38.529929248544256)
(ERα,38.529929248544256)
(FXYD3,38.529929248544256)
(AD,38.529929248544256)
(NLR,38.529929248544256)
(users,35.28620838367894)
(Per2,33.713688092476225)
(nipple,33.713688092476225)
(Zt/g4-MMAE,33.713688092476225)
(circular,33.713688092476225)
(malformation,33.713688092476225)
(HER2-targeted,33.713688092476225)
(hypomethylation,33.713688092476225)
(kinase,32.98475180406469)
(fission,28.897446936408194)
(complexes,28.897446936408194)
(miR-10a,28.897446936408194)
(membrane,28.897446936408194)
(superior,28.897446936408194)
(polymorphisms,28.897446936408194)
(LMICs,28.897446936408194)
(lung/bronchus,28.897446936408194)
(nondestructive,28.897446936408194)
(NSAID,28.897446936408194)
(online,28.897446936408194)
(AMD3100,28.897446936408194)
(cavernous,28.897446936408194)
(PFH-PTX@PLGA,28.897446936408194)
(Carcinoma,28.897446936408194)
(STAT1,28.897446936408194)
(cTn,28.897446936408194)
(CTC,28.897446936408194)
(AION,28.897446936408194)
(ethanolic,28.897446936408194)
(cytology,26.464656287759205)
(LVEF,26.464656287759205)
(DDT,26.464656287759205)
(VDR,26.464656287759205)
(methylation,26.023402071799453)
(trastuzumab,24.738563853048518)
(M,24.738563853048518)
(NIR-SN-GGT,24.08120578034016)
(Resection,24.08120578034016)
(metformin,24.08120578034016)
(Vitamin,24.08120578034016)
(PET/CT,24.08120578034016)
(stigmatization,24.08120578034016)
(neuromas,24.08120578034016)
(nanoplatform,24.08120578034016)
(F-FDG,24.08120578034016)
(Incidence,24.08120578034016)
(PCDH10,24.08120578034016)
(CA-VTE,24.08120578034016)
(NSAIDs,24.08120578034016)
(RON,24.08120578034016)
(hypomethylated,24.08120578034016)
(CDH1,24.08120578034016)
(CK19,24.08120578034016)
(D,24.08120578034016)
(progranulin,24.08120578034016)
(interference,24.08120578034016)
(capecitabine,24.08120578034016)
(BALF,24.08120578034016)
(perceived,24.08120578034016)
(-1,24.08120578034016)
(synchrotron,22.053880239799337)
(FFDM,19.264964624272128)
(SC,19.264964624272128)
(chemotherapy-induced,19.264964624272128)
(replaced,19.264964624272128)
(MORC4,19.264964624272128)
(mastectomies,19.264964624272128)
(transmembrane,19.264964624272128)
(pediatric,19.264964624272128)
(Baicalin,19.264964624272128)
(Asian,19.264964624272128)
(sutegory,19.264964624272128)
(Fresh,19.264964624272128)
(US,19.264964624272128)
(Arabian,19.264964624272128)
(FOXC1,19.264964624272128)
(areola,19.264964624272128)
(sequencing,19.264964624272128)
(CLB-Pt-CLB,19.264964624272128)
(Kenya,19.264964624272128)
(PB-DLL,19.264964624272128)
(third-line,19.264964624272128)
(PAX6,19.264964624272128)
(sleep,19.264964624272128)
(CA,19.264964624272128)
(wild-type,19.264964624272128)
(autoantibodies,19.264964624272128)
(isolation,19.264964624272128)
(CNVs,19.264964624272128)
(chorea,19.264964624272128)
(CLP,19.264964624272128)
(CESM,19.264964624272128)
(extract,19.264964624272128)
(informational,19.264964624272128)
(behaviours,19.264964624272128)
(MSOT,19.264964624272128)
(PF,19.264964624272128)
(BL1-subtype,19.264964624272128)
(fibroblasts,19.264964624272128)
(Saudi,19.264964624272128)
(sprays,19.264964624272128)
(skin,19.264964624272128)
(sutegories,19.264964624272128)
(Japanese,19.264964624272128)
(BRD4,19.264964624272128)
(SRS,19.264964624272128)
(probe,18.588144336999612)
(images,17.81739093786332)
(OS,17.81739093786332)
(lymphedema,17.64310419183947)
(C,17.64310419183947)
(regions,17.64310419183947)
(complications,17.64310419183947)
(baseline,17.64310419183947)
(resistance,17.149733974740705)
(markers,16.56081879645879)
(issues,16.492375902032347)
(DNA,16.492375902032347)
(relapse,16.492375902032347)
(exposure,16.492375902032347)
(appearance,16.492375902032347)
(will,16.492375902032347)
(PFS,16.492375902032347)
(endocrine,16.492375902032347)
(drugs,14.870515469599688)
(miR-34s,14.448723468204097)
(Pathogenic,14.448723468204097)
(CA15-3,14.448723468204097)
(contraception,14.448723468204097)
(Baseline,14.448723468204097)
(KMT2A,14.448723468204097)
(BRCAness,14.448723468204097)
(Mortality,14.448723468204097)
(mother,14.448723468204097)
(plasticity,14.448723468204097)
(covariance,14.448723468204097)
(G,14.448723468204097)
(baicalin,14.448723468204097)
(incorporation,14.448723468204097)
(extracts,14.448723468204097)
(collision,14.448723468204097)
(lifestyle,14.448723468204097)
(late-stage,14.448723468204097)
(derivatives,14.448723468204097)
(aptamer,14.448723468204097)
(glycosylation,14.448723468204097)
(Cabergoline,14.448723468204097)
(disruption,14.448723468204097)
(Traumatic,14.448723468204097)
(Portuguese,14.448723468204097)
(PCI,14.448723468204097)
(sarcomas,14.448723468204097)
(Mammographic,14.448723468204097)
(procedures,14.448723468204097)
(document,14.448723468204097)
(similarities,14.448723468204097)
(erythematous,14.448723468204097)
(derived,14.448723468204097)
(capillaries,14.448723468204097)
(quantification,14.448723468204097)
(dioxide,14.448723468204097)
(SMARCAD1,14.448723468204097)
(applicability,14.448723468204097)
(seroma,14.448723468204097)
(provision,14.448723468204097)
(Almaty,14.448723468204097)
(CS,14.448723468204097)
(granuloma,14.448723468204097)
(troponins,14.448723468204097)
(analytics,14.448723468204097)
(SPIO-Her,14.448723468204097)
(BL1,14.448723468204097)
(analysesResults,14.448723468204097)
(consensus,14.448723468204097)
(literacy,14.448723468204097)
(macroadenomas,14.448723468204097)
(MDA-MB-468,14.448723468204097)
(Oestrogen,14.448723468204097)
(MF3,14.448723468204097)
(TAAs,14.448723468204097)
(microenvironment,14.448723468204097)
(functionality,14.448723468204097)
(Angiogenesis,14.448723468204097)
(guidelines,14.448723468204097)
(anastrozole,14.448723468204097)
(Mutations,14.448723468204097)
(CEDM,14.448723468204097)
(244,14.448723468204097)
(HDGC,14.448723468204097)
(infrared,14.448723468204097)
(distance,14.448723468204097)
(Tamoxifen,14.448723468204097)
(Osteopontin-750,14.448723468204097)
(HER-2,14.448723468204097)
(Surgeons,14.448723468204097)
(Scoring,14.448723468204097)
(Skin,14.448723468204097)
(interval,14.448723468204097)
(low-dose,14.448723468204097)
(Calvarial,14.448723468204097)
(Individuals,14.448723468204097)
(dysplasia,14.448723468204097)
(addressed,14.448723468204097)
(utilized,14.448723468204097)
(food,14.448723468204097)
(disturbances,14.448723468204097)
(Erysipelatoid,14.448723468204097)
(Articles,14.448723468204097)
(ERN,14.448723468204097)
(analogs,14.448723468204097)
(eleven,14.448723468204097)
(mannose,14.448723468204097)
(extract-treated,14.448723468204097)
(Pulmonary,14.448723468204097)
(apatinib,14.448723468204097)
(PAX8,14.448723468204097)
(Dichlorofluorescein,14.448723468204097)
(hyperglycemia,14.448723468204097)
(craniotomy,14.448723468204097)
(percent,14.448723468204097)
(Computer,14.448723468204097)
(Inhibition,14.448723468204097)
(post-diagnosis,14.448723468204097)
(β-Sitosterol-d-glucoside,14.448723468204097)
(PIK3CA,14.448723468204097)
(surgeries,14.448723468204097)
(PCOS,14.448723468204097)
(modulators,14.448723468204097)
(obstacle,14.448723468204097)
(7,14.448723468204097)
(α,14.448723468204097)
(pyrrolizin-5-one,14.448723468204097)
